clinical trial · NCT06545929
Study of Sunobinop on Craving in Alcohol Use Disorder
Alcohol Use DisorderSunobinopPlacebo to match sunobinop
brief summary
The purpose of this study is to evaluate the efficacy of sunobinop compared to placebo on alcohol craving in subjects with moderate to severe alcohol use disorder and these subjects are seeking treatment.
started
Jan 28, 2025
primary completion
Jul 14, 2025
completion
Jul 14, 2025
last updated
Jul 23, 2025
official title
A Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 2 Study to Evaluate Impact of Sunobinop (V117957) on Alcohol Craving in Subjects Diagnosed With Moderate to Severe Alcohol Use Disorder and Seeking Treatment
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol